tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PCRX Stock Latest News

Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) should contact Levi & Korsinsky LLP about pending Class Action – PCRX
Class ActionShareholders that lost money on Pacira BioSciences, Inc.(PCRX) should contact Levi & Korsinsky LLP about pending Class Action – PCRX
4d ago
PCRX
Pacira price target raised to $30 from $22 at Needham
PremiumThe Fly
Pacira price target raised to $30 from $22 at Needham
5d ago
PCRX
Pacira sees FY24 revenue $701M, consensus $695.18M
PremiumThe Fly
Pacira sees FY24 revenue $701M, consensus $695.18M
8d ago
PCRX
Pacira announces five-year objectives to accelerate transition
PremiumThe Fly
Pacira announces five-year objectives to accelerate transition
8d ago
PCRX
Pacira reports Q4 EXPAREL net product sales $147.7M vs. $143.9M last year
PremiumThe Fly
Pacira reports Q4 EXPAREL net product sales $147.7M vs. $143.9M last year
8d ago
PCRX
Pacira price target raised to $18 from $16 at RBC Capital
PremiumThe FlyPacira price target raised to $18 from $16 at RBC Capital
11d ago
PCRX
Pacira receives 510k clearance for iovera Smart Tip
Premium
The Fly
Pacira receives 510k clearance for iovera Smart Tip
11d ago
PCRX
DOMA Perpetual Capital to nominate four candidates to Pacira’s board
Premium
The Fly
DOMA Perpetual Capital to nominate four candidates to Pacira’s board
1M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
1M ago
PCRX
Pacira awarded new U.S. patent covering EXPAREL composition
PremiumThe Fly
Pacira awarded new U.S. patent covering EXPAREL composition
2M ago
PCRX
Pacira announces 104-week safety, efficay data for PCRX-201
PremiumThe Fly
Pacira announces 104-week safety, efficay data for PCRX-201
2M ago
PCRX
Pacira price target lowered to $17 from $25 at Barclays
PremiumThe Fly
Pacira price target lowered to $17 from $25 at Barclays
2M ago
PCRX
Pacira price target raised to $12 from $11 at Piper Sandler
PremiumThe FlyPacira price target raised to $12 from $11 at Piper Sandler
2M ago
PCRX
Pacira BioSciences Reports Q3 2024 Earnings and Strategic Developments
Premium
Company Announcements
Pacira BioSciences Reports Q3 2024 Earnings and Strategic Developments
2M ago
PCRX
Pacira Pharmaceuticals Faces Q3 Loss Amid Revenue Growth
Premium
Company Announcements
Pacira Pharmaceuticals Faces Q3 Loss Amid Revenue Growth
2M ago
8K
PCRX
Pacira sees FY24 revenue $680M-$705M, consensus $692.72M
PremiumThe Fly
Pacira sees FY24 revenue $680M-$705M, consensus $692.72M
2M ago
PCRX
Pacira reports Q3 EPS 79c, consensus 70c
PremiumThe Fly
Pacira reports Q3 EPS 79c, consensus 70c
2M ago
PCRX
Pacira announces CMS established additional payment for iovera in outpatient
PremiumThe Fly
Pacira announces CMS established additional payment for iovera in outpatient
2M ago
PCRX
Pacira (PCRX) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Pacira (PCRX) Q3 Earnings Cheat Sheet
3M ago
PCRX
Pacira Pharmaceuticals Appoints Shawn Cross as CFO
PremiumCompany AnnouncementsPacira Pharmaceuticals Appoints Shawn Cross as CFO
3M ago
8K
PCRX
Pacira appoints Cross as Chief Financial Officer
Premium
The Fly
Pacira appoints Cross as Chief Financial Officer
3M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
Premium
The Fly
Pacira reports inducement grants under Nasdaq listing rule
3M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >